|Bid||0.00 x 1000|
|Ask||0.00 x 900|
|Day's Range||122.46 - 123.59|
|52 Week Range||104.07 - 129.82|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||0.95|
|Expense Ratio (net)||0.20%|
While the U.S. equities market experienced one of their best January start to a new year in decades, investors still pulled billions from U.S. stock-related ETFs. Investors redeemed $25 billion from U.S. ...
Calls are mounting for value stocks and the related ETFs to bounce back this year, a familiar refrain as value trailed growth for much of the decade-long bull market in U.S. stocks. When stocks stumbled ...
Value ETFs seek to capitalize on inefficiencies in the market and have the potential to deliver higher returns with lower volatility.
Spooked by fears of another uptick in market volatility led by previously high-flying growth stocks, some investors are embracing value fare. Some investors have been turning to value exchange traded funds, ...
After years of leading the pack, growth stocks have taken a hit in this year's selling, and ETF investors are turning to the value style as a suitable alternative. For example, the iShares Russell 1000 Value ETF (IWD) has been among the most popular plays in recent weeks, attracting close to $1.1 billion in net inflows over the past week and $2.5 billion in the past month, according to XTF data. In comparison, the large-cap growth-oriented iShares Russell 1000 Growth ETF (IWF) saw $824 million in new inflows over the past month while the the large-cap blend iShares Russell 1000 ETF (IWB) experienced $814 in net inflows.
On December 17, Pfizer’s stock price closed at $43.11, which is an ~1.58% decline from its close of $43.80 on December 14. Pfizer’s stock price grew from $36.22 at the close of the market on December 29, 2017, to $43.11 at the close of the market on December 17, 2018, which reflects ~19% YTD (year-to-date) growth.
October 2018 has been one to forget for U.S. equities, but in a survey by the American Association of Individual Investors, it wasn't much better for bonds as exposure to fixed-income dropped to a 10-year low, reflecting the lockstep move both asset classes made during that month of extreme volatility. Things weren't much better for the S&P 500, which followed the Nasdaq into correction territory and fell by 7% in October--its worst month since September 2011. The Dow Jones Industrial Average fell 1,300 points or 5%, which hasn't happened since January 2016. Investors have been spooked by copious amounts of volatility after a decade-long bull run that has seen the growth fueled by FANG (Facebook, Amazon Netflix, Google) stocks dwindle as the technology sector fell into correction territory.
As has been widely documented, value stocks are struggling this year, but the broader market's October woes are plaguing once beloved growth and momentum fare, potentially opening the door for a long-awaited value resurgence. Some investors have been turning to value exchange traded funds, such as the iShares Russell 1000 Value ETF (IWD) , as shelter-from-the-storm plays amid October's increased volatility. IWD seeks to track the investment results of the Russell 1000® Value Index, which measures the performance of large- and mid- capitalization value sectors of the U.S. equity market.